Successful Treatment of Kasabach-Merritt Phenomenon Arising From Kaposiform Hemangioendothelioma by Sirolimus
- 1 January 2015
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Pediatric Hematology/Oncology
- Vol. 37 (1), 72-73
- https://doi.org/10.1097/mph.0000000000000068
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon: From Vincristine to SirolimusKlinische Padiatrie, 2012
- Sirolimus for the treatment of complicated vascular anomalies in childrenPediatric Blood & Cancer, 2011
- Treatment of childhood kaposiform hemangioendothelioma with sirolimusPediatric Blood & Cancer, 2010
- Indications, tolerance and complications of a sirolimus and calcineurin inhibitor immunosuppression regimen: Intermediate experience in pediatric heart transplantation recipientsPediatric Transplantation, 2010
- Kasabach-Merritt Phenomenon: A Retrospective Study of Treatment with VincristineJournal of Pediatric Hematology/Oncology, 2002